Aleknagik North in Aleknagik North, AK - Clinic/Center

Aleknagik North is a primary clinic (Clinic/center) in Aleknagik North, Alaska. The current practice location for Aleknagik North is 73 Main Street, Aleknagik North, Alaska. For appointments, you can reach them via phone at (907) 842-5201. The mailing address for Aleknagik North is Po Box 130, Dillingham, Alaska and phone number is (907) 842-5201.

Aleknagik North is licensed to practice in * (Not Available) (license number ) and its NPI number is 1235291246. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (907) 842-5201.

Contact Information

	Aleknagik North
	73 Main Street Aleknagik North AK 99555
	(907) 842-5201
	(907) 842-9250

Primary Care Clinic Profile

Full Name	Aleknagik North
Speciality	Clinic/center
Location	73 Main Street, Aleknagik North, Alaska
Authorized Official Name and Position	Robert Clark (CEO)
Authorized Official Contact	9078425201
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Aleknagik North Po Box 130 Dillingham AK 99576-0130 Ph: (907) 842-5201	Aleknagik North 73 Main Street Aleknagik North AK 99555 Ph: (907) 842-5201

NPI Details:

NPI Number	1235291246
Provider Enumeration Date	12/15/2006
Last Update Date	10/06/2023

Medical Identifiers

Medical identifiers for Aleknagik North such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1235291246	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
261Q00000X	Clinic/center	(* (Not Available))	Primary

News Archive

Abiomed fiscal fourth quarter revenue increases 24% to $28.5 million

Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported fourth quarter fiscal 2011 revenue of $28.5 million, up 24% compared to revenue of $23.0 million in the same period of fiscal 2010.

Matrix signs MOU with PharmaVentures

Matrix Corporate Capital and PharmaVentures Limited today announced the signing of a Memorandum of Understanding ("MOU") covering strategic transactions in the biotech, pharmaceutical and med tech sectors. The companies will work together to identify licensing, buyout, investment, IPO and consolidation opportunities which bring together both strategic expertise and capital from Europe's dedicated healthcare investors.

Tobacco consumption raises risk of death in comparison with non-smokers

Researchers from the Polytechnic University of Cartagena (UPCT) estimate that each pack of cigarettes really costs €107 for men and €75 for women, when premature death is taken into account. These figures confirm previous studies, and are of key importance in the cost-benefit analysis of smoking-prevention policies.

Children who use community health centers may be at a particularly high risk of being obese

Children who use community health centers may be at a particularly high risk of being obese, according to a new study. This association between obesity and the type of health delivery system used was present regardless of race, ethnicity or geographic characteristics.

Aleknagik North - Primary Care in Aleknagik North, AK